サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：ナルコレプシー治療薬市場：タイプ別、製品別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2023年～2030年
市場調査レポート
商品コード
1419095

ナルコレプシー治療薬市場：タイプ別、製品別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2023年～2030年

Narcolepsy Therapeutics Market, By Type, By Product, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 322 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ナルコレプシー治療薬市場：タイプ別、製品別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2023年～2030年
出版日: 2024年01月01日
発行: AnalystView Market Insights
ページ情報: 英文 322 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

ナルコレプシー治療薬市場規模は2022年に34億3,000万米ドルとなり、2023年から2030年にかけてCAGR 8.34%で拡大すると予測されています。

ナルコレプシー治療薬市場- 市場力学

睡眠障害の有病率の増加、研究開発活動と投資の増加が市場需要を促進

研究開発費と活動の増加、疾患有病率の上昇、革新的な医薬品の発売は、市場拡大を後押しする主な要因の一部です。米国国立神経疾患・脳卒中研究所（NINDS）の推計によると、ナルコレプシーは米国で13万5,000～20万人が罹患しています。今後数年間で、ナルコレプシーと診断される人の数は増加する可能性が高いです。予測期間中、市場拡大を促進する要因の1つは患者数の増加です。National Organization for Rare Disordersによると、約2,000人に1人がこの疾患に罹患しています。同様に、American Academy of Neurology（米国神経学会）の調査では、有病率は人口10万人あたり20～60人とされています。

市場が拡大しているのは、疾患の治療に新しい治療法を導入するための研究開発（R&D）の取り組みが増加しているためです。近年の研究開発活動の加速により、今後数年のうちに新たな治療法が導入されると予想されます。例えば、2021年5月、武田薬品工業株式会社は、ナルコレプシー治療薬の研究開発を発表しました。

ナルコレプシー治療薬市場-セグメンテーション分析：

ナルコレプシー治療薬の世界市場は、タイプ、製品、地域に基づいて区分されます。

タイプ別では、カタプレキシー、カタプレキシーを伴わないで分類されます。市場を独占しているのは、カタプレキシーセグメントです。患者の主な症状としてカタプレキシーが増加していることが、同セグメントの成長を後押ししています。

市場は製品によって、中枢神経系刺激薬、オキシベートナトリウム、三環系抗うつ薬に分類されます。オキシベートナトリウムは市場を独占しており、予測期間中もその優位性を維持するとみられます。珍しい神経疾患患者のための中枢神経刺激薬に関する研究開発努力の高まりが、このセグメントの成長を促進すると予想されます。

ナルコレプシー治療薬市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。

ナルコレプシー治療薬市場-競合情勢：

ナルコレプシー治療薬市場は、少数のプレイヤーが世界市場を独占しており、その性質上、断片化されていません。同市場の主要企業は、急速な投資やM&Aとともに、新製品の設計に注力しています。例えば、2022年5月、Axsome Therapeutics, Inc.は、米国市場においてJazz PharmaceuticalsからSunosiを獲得したと発表しました。

目次

第1章 ナルコレプシー治療薬市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ナルコレプシー治療薬の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 ナルコレプシー治療薬業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 ナルコレプシー治療薬市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 ナルコレプシー治療薬市場情勢

  • ナルコレプシー治療薬市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 ナルコレプシー治療薬市場：タイプ別

  • 概要
    • タイプ別のセグメントシェア分析
    • カタプレキシー
    • カタプレキシーを伴わない

第8章 ナルコレプシー治療薬市場：製品別

  • 概要
    • 製品別のセグメントシェア分析
    • 中枢神経系刺激薬
    • オキシベートナトリウム
    • 三環系抗うつ薬

第9章 ナルコレプシー治療薬市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東とアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析：ナルコレプシー治療薬業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Teva Pharmaceutical Industries Ltd.
    • Avadel Pharmaceuticals
    • Jazz Pharmaceuticals, Inc.
    • Takeda Pharmaceutical Company
    • Harmony Biosciences
    • Novartis AG
    • Rhodes Pharmaceuticals LP
    • Axsome Therapeutics, Inc.
    • Janssen Global Services, LLC
    • Ligand Pharmaceuticals Incorporated
    • Shionogi Inc.
    • Eli Lilly and Company
    • Others

第11章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Narcolepsy Therapeutics Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Narcolepsy Therapeutics Market, by Type 2018-2030 (USD Million)
  • TABLE Narcolepsy Therapeutics Market: Product Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Narcolepsy Therapeutics Market, by Product 2018-2030 (USD Million)
  • TABLE Narcolepsy Therapeutics Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Narcolepsy Therapeutics Market, by End-User 2018-2030 (USD Million)
  • TABLE Narcolepsy Therapeutics Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Narcolepsy Therapeutics Market, by Region 2018-2030 (USD Million)
  • TABLE North America Narcolepsy Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Narcolepsy Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Narcolepsy Therapeutics Market, by Product, 2018-2030 (USD Million)
  • TABLE North America Narcolepsy Therapeutics Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Narcolepsy Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Narcolepsy Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Narcolepsy Therapeutics Market, by Product, 2018-2030 (USD Million)
  • TABLE Europe Narcolepsy Therapeutics Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Narcolepsy Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Narcolepsy Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Narcolepsy Therapeutics Market, by Product, 2018-2030 (USD Million)
  • TABLE Asia Pacific Narcolepsy Therapeutics Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Narcolepsy Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Narcolepsy Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Narcolepsy Therapeutics Market, by Product, 2018-2030 (USD Million)
  • TABLE Latin America Narcolepsy Therapeutics Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Narcolepsy Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Narcolepsy Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Narcolepsy Therapeutics Market, by Product, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Narcolepsy Therapeutics Market, by End-User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Narcolepsy Therapeutics Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Type segment market share analysis, 2022 & 2030
  • FIGURE Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Product segment market share analysis, 2022 & 2030
  • FIGURE Product segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-User segment market share analysis, 2022 & 2030
  • FIGURE End-User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Narcolepsy Therapeutics Market share and leading players, 2022
  • FIGURE Europe Narcolepsy Therapeutics Market share and leading players, 2022
  • FIGURE Asia Pacific Narcolepsy Therapeutics Market share and leading players, 2022
  • FIGURE Latin America Narcolepsy Therapeutics Market share and leading players, 2022
  • FIGURE Middle East and Africa Narcolepsy Therapeutics Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Narcolepsy Therapeutics Market share analysis by country, 2022
  • FIGURE Germany Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Narcolepsy Therapeutics Market share analysis by country, 2022
  • FIGURE India Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Narcolepsy Therapeutics Market share analysis by country, 2022
  • FIGURE Brazil Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Narcolepsy Therapeutics Market share analysis by country, 2022
  • FIGURE Saudi Arabia Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Narcolepsy Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV2160

REPORT HIGHLIGHT

Narcolepsy Therapeutics Market size was valued at USD 3,430 Million in 2022, expanding at a CAGR of 8.34% from 2023 to 2030.

A lifelong sleep illness that causes uncontrollably sudden episodes of extreme sleepiness called as narcolepsy which impacts all facets of a patient's life and makes daily tasks challenging. Narcolepsy can be treated symptomatically with medications that promote wakefulness and raise dopamine release at the presynaptic level.

Narcolepsy Therapeutics Market- Market Dynamics

Increasing prevalence of sleep disorder, increasing R&D activities & investments is to propel market demand

Increasing R&D expenditures and activities, rising disease prevalence, and the launch of innovative medicinal goods are some of the main causes propelling market expansion. Narcolepsy affects between 135,000 and 200,000 people in the United States, according to estimates from the National Institute of Neurological Disorders and Stroke (NINDS). In the upcoming years, there will likely be a rise in the number of people with narcolepsy diagnoses because the disease is more common in those who experience higher levels of stress. Over the forecast period, one of the key drivers propelling the market expansion is an increase in the patient base. As per the National Organization for Rare Disorders, around 1 in 2,000 individuals are affected with the condition. In a similar vein, the American Academy of Neurology study found that the prevalence of disease varies from 20 to 60 in 100,000 people.

The market is growing because of an increase in research and development (R&D) efforts to introduce novel therapeutic solutions for the treatment of disease. New treatment alternatives will be introduced in the upcoming years because of the recent acceleration of research and development activity. For example, in May 2021, Takeda Pharmaceutical Company Limited announced that research and development for narcolepsy medication.

Narcolepsy Therapeutics Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.34% over the forecast period (2023-2030)
  • Based on Type segmentation, cataplexy segment was predicted to show maximum market share in the year 2022, owing to its high adoption of novel drugs such as WAKIX, Xyrem, Xywav, etc.
  • Based on Product segmentation, sodium oxybate was the leading segment in 2022, mainly due to growing awareness levels pertaining to diagnosis.
  • On the basis of region, North America was the leading revenue generator in 2022. Asia Pacific expected to grow at the fastest CAGE over the forecast period.

Narcolepsy Therapeutics Market- Segmentation Analysis:

The Global Narcolepsy Therapeutics Market is segmented on the basis of Type, Product, and Region.

The market is divided into two categories based on Type: cataplexy and without cataplexy. The cataplexy segment dominates the market. The rise in a prevalence of cataplexy as a major symptom in patients is boosting the segment growth.

The market is divided into three categories based on Product: Central Nervous System Stimulants, Sodium Oxybate, and Tricyclic Antidepressants. The Sodium Oxybate segment dominates the market and is likely to maintain its dominance during the forecast period. It is anticipated that rising R&D efforts pertaining to CNS stimulants for patients with uncommon neurological illnesses will drive the segment's growth.

Narcolepsy Therapeutics Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Narcolepsy Therapeutics Market- Competitive Landscape:

The Narcolepsy Therapeutics market is less fragmented in nature with few players dominating global market. Key players in the market are focused on new product design paired with the rapid investment and mergers & acquisitions. For example, in May 2022, Axsome Therapeutics, Inc. announced the attainment of Sunosi from Jazz Pharmaceuticals across U.S. market.

Recent Developments:

In May 2023, Avadel Pharmaceuticals received final U.S. FDA approval for its drug Lumryz for the treatment of narcolepsy.

In January 2022, the U.S. FDA approved Orphan Drug Exclusivity for Jazz Pharmaceuticals' Xywav for the treatment of idiopathic hypersomnia in adults.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NARCOLEPSY THERAPEUTICS MARKET KEY PLAYERS

  • Teva Pharmaceutical Industries Ltd.
  • Avadel Pharmaceuticals
  • Jazz Pharmaceuticals, Inc.
  • Takeda Pharmaceutical Company
  • Harmony Biosciences
  • Novartis AG
  • Rhodes Pharmaceuticals L.P.
  • Axsome Therapeutics, Inc.
  • Janssen Global Services, LLC
  • Ligand Pharmaceuticals Incorporated
  • Shionogi Inc.
  • Eli Lilly and Company
  • Others

GLOBAL NARCOLEPSY THERAPEUTICS MARKET, BY TYPE

  • Cataplexy
  • Without Cataplexy

GLOBAL NARCOLEPSY THERAPEUTICS MARKET, BY PRODUCT

  • Central Nervous System Stimulants
  • Sodium Oxybate
  • Tricyclic Antidepressants

GLOBAL NARCOLEPSY THERAPEUTICS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Narcolepsy Therapeutics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Narcolepsy Therapeutics Market Snippet by Type
    • 2.1.2. Narcolepsy Therapeutics Market Snippet by Product
    • 2.1.3. Narcolepsy Therapeutics Market Snippet by Country
    • 2.1.4. Narcolepsy Therapeutics Market Snippet by Region
  • 2.2. Competitive Insights

3. Narcolepsy Therapeutics Key Market Trends

  • 3.1. Narcolepsy Therapeutics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Narcolepsy Therapeutics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Narcolepsy Therapeutics Market Opportunities
  • 3.4. Narcolepsy Therapeutics Market Future Trends

4. Narcolepsy Therapeutics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Narcolepsy Therapeutics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Narcolepsy Therapeutics Market Landscape

  • 6.1. Narcolepsy Therapeutics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Narcolepsy Therapeutics Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Cataplexy
    • 7.1.3. Without Cataplexy

8. Narcolepsy Therapeutics Market - By Product

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
    • 8.1.2. Central Nervous System Stimulants
    • 8.1.3. Sodium Oxybate
    • 8.1.4. Tricyclic Antidepressants.

9. Narcolepsy Therapeutics Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Narcolepsy Therapeutics Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Narcolepsy Therapeutics Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.7.5. Overview
      • 9.3.7.6. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.7. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.7.8. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.3.8. France
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.8.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.9. Russia
      • 9.3.9.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.9.3. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.3.10. Netherlands
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.10.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.11. Sweden
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.3.12. Poland
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.12.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.3.13. Rest of Europe
      • 9.3.13.1. Overview
      • 9.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.13.4. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.3.13.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Narcolepsy Therapeutics Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.6.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.7.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.8.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.9.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.10.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.11.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.12.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.13.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.4.14.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Narcolepsy Therapeutics Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.6.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.7.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.8.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.9.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.5.10.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Narcolepsy Therapeutics Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.6.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.7.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.8.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.9.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.10.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.11.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 9.6.12.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Narcolepsy Therapeutics Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Teva Pharmaceutical Industries Ltd.
    • 10.2.2. Avadel Pharmaceuticals
    • 10.2.3. Jazz Pharmaceuticals, Inc.
    • 10.2.4. Takeda Pharmaceutical Company
    • 10.2.5. Harmony Biosciences
    • 10.2.6. Novartis AG
    • 10.2.7. Rhodes Pharmaceuticals L.P.
    • 10.2.8. Axsome Therapeutics, Inc.
    • 10.2.9. Janssen Global Services, LLC
    • 10.2.10. Ligand Pharmaceuticals Incorporated
    • 10.2.11. Shionogi Inc.
    • 10.2.12. Eli Lilly and Company
    • 10.2.13. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us